メタ情報
| meta description平均長 | 153.29 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 188 |
|---|
| ページあたり内部リンク平均 | 51.61 |
|---|
内部リンク 深さヒストグラム
| キー | 値 |
|---|
| 0 | 120 |
| 1 | 2559 |
| 2 | 216 |
| 3 | 162 |
| 4 | 39 |
| 5 | 52 |
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| personal | 1 |
| your | 0.757501 |
| information | 0.738216 |
| prescription | 0.733004 |
| data | 0.633996 |
| may | 0.63125 |
| supply | 0.590154 |
| not | 0.565282 |
| medicines | 0.559369 |
| you | 0.553657 |
| their | 0.527667 |
| training | 0.517703 |
| should | 0.505275 |
| controlled | 0.501327 |
| will | 0.484599 |
| programme | 0.482853 |
| vaccine | 0.44056 |
| disclosure | 0.44056 |
| which | 0.435696 |
| patient | 0.427318 |
| extension | 0.425368 |
| requirements | 0.425 |
| where | 0.423351 |
| pharmacist | 0.418939 |
| must | 0.410107 |
| legal | 0.402378 |
| they | 0.399832 |
| CPD | 0.384494 |
| required | 0.38125 |
| purposes | 0.379793 |
| consultation | 0.377177 |
| have | 0.376941 |
| vaccination | 0.371465 |
| process | 0.37006 |
| was | 0.365809 |
| details | 0.36054 |
| legislation | 0.359594 |
| can | 0.353885 |
| pharmacy | 0.353376 |
| out | 0.351909 |
| any | 0.350487 |
| HSE | 0.348711 |
| open | 0.345816 |
| our | 0.337739 |
| drugs | 0.3375 |
| Healthmail | 0.334218 |
| appropriate | 0.33125 |
| prescriptions | 0.323673 |
| provided | 0.323393 |
| administer | 0.319026 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| disclosure | open | 4.005836 | 118 |
| controlled | drugs | 3.974832 | 99 |
| Expert | Taskforce | 3.963039 | 96 |
| Common | Conditions | 3.935796 | 74 |
| Medicinal | Products | 3.901876 | 92 |
| High | Tech | 3.872494 | 71 |
| Data | Protection | 3.85162 | 72 |
| assistants | pharmaceutical | 3.538929 | 80 |
| Conditions | Service | 3.458023 | 73 |
| Department | Health | 3.444359 | 137 |
| Drugs | Misuse | 3.408494 | 50 |
| Code | Conduct | 3.327029 | 52 |
| absence | temporary | 3.297753 | 36 |
| Disclosure | Open | 3.285443 | 44 |
| medicinal | products | 3.272747 | 53 |
| out | set | 3.223736 | 120 |
| judgement | professional | 3.210507 | 76 |
| Implementation | Oversight | 3.192074 | 32 |
| Technological | University | 3.14064 | 40 |
| Characteristics | Product | 3.140016 | 28 |
| Characteristics | SPC | 3.140016 | 28 |
| Chief | Officer | 3.117083 | 45 |
| Pharmaceutical | Society | 3.107667 | 44 |
| Control | Prescription | 3.107667 | 44 |
| Control | Supply | 3.077517 | 44 |
| Assessment | System | 3.059545 | 32 |
| Institute | Irish | 3.040358 | 48 |
| Group | Oversight | 3.030937 | 36 |
| methylated | spirits | 3.01203 | 28 |
| been | has | 3.010803 | 125 |
| Joanne | Kissane | 3.006564 | 24 |
| assistant | pharmaceutical | 2.999842 | 52 |
| Health | Minister | 2.912538 | 84 |
| East | South | 2.869705 | 24 |
| Product | Summary | 2.865523 | 28 |
| Immunisation | National | 2.860353 | 42 |
| Organisation | Verification | 2.859896 | 24 |
| Emerging | Risks | 2.84898 | 20 |
| Continuing | Professional | 2.848825 | 32 |
| Common | Service | 2.845063 | 55 |
| Review | Therapy | 2.813672 | 24 |
| Development | Professional | 2.803976 | 33 |
| parties | third | 2.781849 | 28 |
| Continuing | Development | 2.781268 | 26 |
| data | protection | 2.770994 | 75 |
| TCQR | route | 2.769095 | 20 |
| Administration | Parenteral | 2.769095 | 20 |
| PAMT | Parenteral | 2.769095 | 20 |
| controlled | schedule | 2.762214 | 52 |
| IMVO | Organisation | 2.740338 | 24 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録